Health Tech Capitol | Exact Sciences, Mayo Clinic say they’ve developed blood test for liver cancer
16235
post-template-default,single,single-post,postid-16235,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Exact Sciences, Mayo Clinic say they’ve developed blood test for liver cancer

06 Jun Exact Sciences, Mayo Clinic say they’ve developed blood test for liver cancer

Posted at 15:04h in Uncategorized by
0 Likes

Exact Sciences Corp. and the Mayo Clinic say they’ve developed a blood test that correctly identified 95 percent of the cases of a common form of liver cancer.

The news, released Tuesday in a presentation at a major conference of gastroenterologists, is a signal that the liver cancer blood test could be the second product that Exact, of Madison, and Mayo, of Rochester, Minnesota, will seek to bring to market, following Cologuard, their stool-based test for colorectal cancer. The liver cancer blood test could be available in about three years if all goes well, Exact CEO Kevin Conroy said.

But it’s just the start.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.